可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 彭 健,吴平生,刘伊丽,等. Brugada综合征—心电图右束支传导阻滞伴STV1~V3抬高伴心脏性猝死二例[J].中华心律失常杂志, 1999,2:145-146.
[2] Gonzalez Rebollo JM,Hernandez Madrid A. Recurent ventricular fibrillation during a febrile illness in a patient with the Brugada syndrome[J].Rev Esp Cardiol,2000,53(5):755.
[3] With Brugada syndrome. The circadian pattern of the development of ventricular fibrillation in patients[J].Eur Heart J,1999,20(6):465-470.
[4] Brugada J,Brugada R,Brugada P. Right bundle branch block,ST segment elevation in leads V1~ V3:a marker for sudden death in patients without demonstratable structural heart disease[J]. Circulation, 1998,97:457-460.
[5] Gussak I,Antzelevitch C. The Brugada syndrome:clinical,electrophysiologic and genetic aspects[J].J Am Coll Cardiol,1999,33(1):5-15.
[6] Takagi M,Aihara N. Clinical characteristics of patients with spontaneous or inducible ventricular fibrillation without apparent heart disease presenting with J wave and ST segment elevation in inferior leads[J].J Cardiovasc Electrophysiol,2000,11 (8):844-848.
[7] Kalla H,Yan GX,Marinchak R. Ventricular fibrillation in a patient with prominent J(Osborn) waves and ST segment elevation in the inferior electrocardiographic leads:a Brugada syndrome variant?[J].J Cardiovasc Electrophysiol,2000,11(1):95-98.
[8] Naccarella F,Maranga S. Clinical characteristics, familial distribution and preliminary genetic data in 9 different families with “Brugada′s syndrome”[J].G Ital Cardiol,1999,29(12):1488-1498.
[9] Itoh H,Shimi ZU,Ino H,et al. Arrhythmic evets and sT-segment elevation in Brugada syndrome[J].J Am Coll Cardiol, 2000, 35:100A.
[10]Chalvidan T,Deharo JC. Near fatal electrical storm in a patient equipped with an implantable cardioverter defibrillator for Brugada syndrome[J].Pacing Clin Electrophysiol, 2000,23(3):410-412.
[11]Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation[J].Circulation,1999,100(15):1660-1666.
[12]Brugada P,Brugada R. Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts[J].Am J Caridol,1999,83(5B):98D-100D.
[13]Fujiki A,Usui M. ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs:insight into the mechanism of Brugada syndrome[J].J Cardiovasc Electrophysiol,1999,10(2):214-218.
[14]Gussak I,Chaitman BR. Rapid ventricular repolarization in rodents: electrocardiographic manifestations, molecular mechanisms,and clinical insights[J].J electrocardiol,2000,33(2):159-170.
[15]Dumaine R,Towbin JA. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent[J].Circ Res,1999,85(9):803-809.
[16]Baroudi G,Carbonneau E. SCN5A mutation (T1620M) causing Brugada syndrome exhibits different phenotypes when expressed in Xenopus oocytes and mammalian cells[J].FEBS
Lett,2000,467(1):12-16.
[17]Rook MB,Alshinawi CB. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome[J].Cardiovasc Res,1999,44(3):507-517.
[18]Akai J,Makita N. A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome[J].FEBS Lett,2000,479(1-2):29-34.
[19]Veldkamp MW,Viswanathan PC. Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel[J].Circ Res,2000,86(9):E91-E97.
[20]Deschenes I,Baroudi G. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes[J].Cardiovasc Res,2000,46(1):55-65.
[21]Bowles NE,Bowles KR. The“final common pathway”hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy[J].Herz,2000,25(3):168-175.